Galderma Group AG
GALD
Rang in aandelen
#459
Galderma Group AG operates as a dermatology company worldwide. The company... Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.
Aandeelprijs
$224.81
Marktkapitalisatie
$52.42B
Verandering (1 dag)
6.31%
Verandering (1 jaar)
31.28%
Land
CH
Handel Galderma Group AG (GALD)
Categorie
Healthcare
Koersgeschiedenis voor Galderma Group AG (GALD)
Hoogste slotkoers: $217.37 op 2026-10-01
Laagste slotkoers: $68.55 op 2024-03-01
Laagste slotkoers: $68.55 op 2024-03-01
Koersgeschiedenis van Galderma Group AG van 2024 tot 2026
Jaarlijkse koersprestatie
| Jaar | Prestaties |
|---|---|
| 2026 (TTM) | 0.90% |
| 2025 | 96.13% |
| 2024 | 0.00% |
Aandelenkoers van vergelijkbare bedrijven of concurrenten
| Bedrijf | Aandelenkoers | Verandering 1jr% | Land |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $165.31 | 23.62% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $18.43 | -4.03% |
IN
|
|
| $6.89 | -24.78% |
CN
|
